Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer.

Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA, Perou CM.

J Biol Chem. 2001 Nov 9;276(45):42259-67. Epub 2001 Aug 31.

2.

Characterization of RERG: an estrogen-regulated tumor suppressor gene.

Key MD, Andres DA, Der CJ, Repasky GA.

Methods Enzymol. 2006;407:513-27.

PMID:
16757349
3.

Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.

Hanker AB, Morita S, Repasky GA, Ross DT, Seitz RS, Der CJ.

Methods Enzymol. 2008;439:53-72. doi: 10.1016/S0076-6879(07)00405-3.

PMID:
18374156
4.

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.

Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC.

Oncogene. 2003 May 15;22(19):2897-909.

PMID:
12771940
6.
7.

Rig is a novel Ras-related protein and potential neural tumor suppressor.

Ellis CA, Vos MD, Howell H, Vallecorsa T, Fults DW, Clark GJ.

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9876-81. Epub 2002 Jul 9.

8.

Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice.

Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Reimann K, Razak G, Virgili F.

Lipids. 2004 May;39(5):459-67.

PMID:
15506241
9.

A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.

Wang L, Yang L, Luo Y, Zheng Y.

J Biol Chem. 2003 Nov 7;278(45):44617-25. Epub 2003 Aug 25.

10.

Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases.

Wang AG, Fang W, Han YH, Cho SM, Choi JY, Lee KH, Kim WH, Kim JM, Park MG, Yu DY, Kim NS, Lee DS.

J Korean Med Sci. 2006 Oct;21(5):891-6.

11.

Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.

Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.

J Cell Physiol. 2004 Sep;200(3):440-50.

PMID:
15254972
13.

Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.

Itoh T, Karlsberg K, Kijima I, Yuan YC, Smith D, Ye J, Chen S.

Mol Cancer Res. 2005 Apr;3(4):203-18.

14.

Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.

Yang C, Trent S, Ionescu-Tiba V, Lan L, Shioda T, Sgroi D, Schmidt EV.

Cancer Res. 2006 Dec 15;66(24):11649-58.

15.

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.

Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.

Breast Cancer Res. 2008;10(6):R104. doi: 10.1186/bcr2208. Epub 2008 Dec 5.

16.

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD.

Clin Cancer Res. 1999 Sep;5(9):2511-9.

17.

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I.

Endocr Relat Cancer. 2006 Dec;13(4):1109-20.

18.
19.

Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.

Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, LaPushin R, Andreeff M, Fang B, Yu Y, Bast RC Jr.

Cancer Res. 2002 Dec 15;62(24):7264-72.

20.

Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schütte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL.

PLoS One. 2008 Aug 20;3(8):e2987. doi: 10.1371/journal.pone.0002987.

Items per page

Supplemental Content

Write to the Help Desk